Again, there was no statistical difference in the age of onset, sex distribution, clinical symptoms, primary lesion of the tumor, and Ann Arbor staging between p-mTOR + and p-mTOR- patients (p > 0.05). The gene discussed is MTOR; the disease is neoplasm.